Introduction {#s1}
============

Cancer is a critical public health problem in the entire world,^[@R1]-[@R5]^ and it is estimated that there exist more than 10 million individuals with cancer throughout the world.^[@R6]^ For decades, scientists could not find a safe way (or drug) to treat cancer and its related complications,^[@R7],[@R8]^ Therefore, try to find or search for new effective anti-cancer agents is a critical strategy in any cancer therapy program. Studies indicated that 30% to 50% of cancers are preventable^[@R9]^ and various factors including healthy diet^[@R10]^ (especially diet rich in flavonoids),^[@R11]^ physical activities^[@R12]^ and avoidance of smoking,^[@R13]^ alcohol drinking,^[@R14]^ etc. can reduce the probability of cancer occurrence.

"*Let food be thy medicine and thy medicine be thy food*" was quoted by Hippocrates more than 2000 years ago,^[@R15]^ and for centuries oral medicinal plants and their metabolites have widely been applied to alleviate and treat a wide range of human diseases such as inflammation, wounds and infection.^[@R16],[@R17]^ Thanks to recent advances in biochemical approaches, anti-cancer, anti-diabetic, anti-microbial, anti-inflammatory and antioxidant properties of phenolic acids and flavonoids have been widely reported and researchers considered these bioactive compounds as a valuable source of natural agents to expand their plans to find new drugs.

Date palm, with scientific name *Phoenix dactylifera,* is a flowering tree widely planted for its sweet fruits. The fruits of dates contain a high rate of carbohydrates (44%-88%), 15 salts and mineral elements, protein (2.3%-5.6%), a considerable amount of roughage (6.4%-11.5%) and vitamins.^[@R18]^ On the other hand, date palm pollen (DPP) is a white to yellow soft powder among the branches of palm trees which orally consumed for many different proposes including the increases of ovary and testis weight,^[@R19]^ the strengthen of fertility power^[@R20]^ and the treatment of ovarian cysts.^[@R21]^ Though the anticancer activity of date fruits was previously reported,^[@R22]^ there is not any report about the anti-angiogenic activity of its pollen extract in the literature. So, the current study aims to scrutinize the anti-angiogenic property of DPP hydro-alcoholic extract *in vitro*.

Material and Methods {#s2}
====================

Plant material {#s2-1}
--------------

DPP soft powder was prepared from Agriculture Research Center of Razi University, Kermanshah, Iran in September 2015.

Preparation of DPP hydro-alcoholic extract {#s2-2}
------------------------------------------

To prepare DPP hydro-alcoholic extract, its soft powder was mixed with a 1:1 ratio (w/v) of 50% ethanol and then slowly stirred for 24 hours at 4°C. The extract was then filtered and centrifuged at 12 000 g for 20 minutes at 4°C. Then, the supernatant was collected. In the next step, using a rotary the extract was concentrated. Then it was incubated at 37°C for 72 hours in order to achieve a dry powder.

Cell culture {#s2-3}
------------

The human umbilical vein endothelial cells (HUVECs) were used to evaluate the cytotoxic activity, angiogenic-related gene expression, and anti-angiogenic potential of date palm pollen extract (DPPE). To culture the cells, a mixed medium of MCBD-131 was used. The HUVECs cells were obtained from nitrogen flask and after thawing at 37°C, a complete culture medium was added and the prepared mixture was centrifuged for 5 minutes at 1000 g. Then the supernatant was discarded and the fresh culture medium was substituted. Then, the suspension was transferred to the flask and then endothelial cells were passaged. Passages 3 to 5 were applied for further steps.

Cytotoxicity and proliferation assays {#s2-4}
-------------------------------------

The lactate dehydrogenase (LDH) assay was used to measure cell viability. The experimental protocol for LDH assay was performed based on Linford's method.^[@R23]^ Cells were cultured in a 96-well culture plate at a density of 1×10^4^ cells/well in MCDB131 supplemented containing 2% FBS incubated for 24 hours. Afterward, different concentrations (25-1000 µg/mL) of the hydro-alcoholic extract of DPP were added to the wells and the plates were incubated for an additional 48 hours. Finally, 100 µL of supernatant was transferred to a 96-wells cultured plate and LDH release was determined by LDH kit at 490 nm with background diminution at 630 nm, respectively.

To assay cell proliferation, after culturing the cells like a previous step (LDH test), the cells were counted after treating with different concentrations (25-1000 µg/mL) of the DPP hydro-alcoholic extract (for 48 hours) by MTT assay. All these steps were repeated in triplicates.

HUVECs capillary tube formation in three-dimensional collagen gel {#s2-5}
-----------------------------------------------------------------

In this experiment, passages 3-5 of HUVECs were used. Cytodex 3 microcarrier beads (Amersham Pharmacia Biotech) were prepared based on the manufacturer's instructions. The HUVECs were mixed with the Cytodex 3 microcarrier beads by mildly shaking the cell suspension and microcarriers every 20 minutes in MCDB131 supplemented with 10% FCS for 4 hours at 37°C and 5% CO2. Thereafter, the cell suspension with microcarriers was transferred to a 24-well tissue culture plate and incubated for 12-16 hours under the same conditions. Then in the following day, the cell-incorporated beads were mixed with a collagen solution (collagen type I, 10X MCDB131, 23 mg/mL NaHCO3 and FCS with a ratio of 7.5:1:1:0.5, respectively) on ice, and 50 μL of the solution was added to each well of the 96-well plate and allowed to rigidify in the incubator for 20 minutes at 37°C and 5% CO2. Afterwards, 250 μL of MCDB131 with different concentrations of extract (25-1000 µg/mL) were added. The effects of extract on sprout formation were investigated and the percentage decrease in sprout formation after three days of treatment compared to the control.

Real-time PCR {#s2-6}
-------------

Total RNA extraction was performed by RNAX-Plus (Cinaclon, Iran) (after 18 hours of incubating HUVECs administered with various doses of the extract \[25-600 µg/mL\] at 37°C, and 80% humidity) and cDNA synthesis from RNAs was done by EURE~X~ kit according to its instruction. The expression of *VEGF*, *MMP-2* and *MMP-9* mRNA levels were assessed with SYBR Green I and amplified with the Rotor-Gene 6000 system (Corbett Research, Australia) by real-time polymerase chain reaction (PCR). Beta-actin (β-actin) was used to normalize the expression results as a reference gene. Analysis of relative gene expression data gained from three sets of experiments was carried out by 2^--ΔΔCT^ method.

Molecular docking {#s2-7}
-----------------

### Preparation of ligand and receptor {#s2-7-1}

To perform molecular docking simulation (fully blind docking) the following steps were done. First, the 3D crystallographic structures of vascular endothelial growth factor receptor 1 (VEGFR-1) (PDB ID: 3HNG^[@R24]^), VEGFR-2 (PDB ID: 2XIR), VEGF (PDB ID: 2VPF^[@R25]^) and circulating tumor DNA (ctDNA) (PDB ID: 1BNA^[@R26]^) were obtained from the Protein Data Bank (<http://www.rcsb.org/pdb/home/home.do>). The 3D structures of DPP secondary metabolites were obtained from PubChem database in ".*sdf*" format. The OpenBabel tool was used to construct ligands ".*pdb**"*** files. The AM1 semi-empirical method in HyperChem was used to optimize the chemical structure of the selected ligands ([Fig. 1](#F1){ref-type="fig"}). Molecular docking simulation (blind docking) was performed using the AutoDock 4.2.6 tool .^[@R27]^ First, the water molecules and other unrelated atoms were eliminated from the initial structures of the selected receptors, and then missing hydrogens and Gasteiger/Kollman charges were added to the receptor and ligand structures. Afterwards, pre-calculation of grid maps was performed using AutoGrid. Next, the docking simulation was performed by inserting a grid map with 60 × 60 × 60 Å points and a grid point spacing of 0.375 Å which was centered on the receptor. The number of independent docking runs performed for each docking simulation was set to 200 with 25 000 000 energy evaluations for each run. For calculation of other parameters, the default values of program were used. Finally, the best conformer with the lowest binding energy was selected for each docking simulation. All generated poses were evaluated using Schrodinger suite 2015 (free trial version) (<https://www.schrodinger.com/>) and PyMOL, in order to detect the type of interactions including π-π, H-bond and cation-π interactions associated with ligand binding mode.
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Statistical analysis {#s2-8}
--------------------

Data analysis and diagram drawing for toxicity and inhibition of the HUVECs' growth were performed by GraphPad Prism® software.^[@R30]^ The *CC*~50~ and IC~50~ values were computed using charts and obtained linear equation. The statistical significance of experimental data was determined using the one-way or two-way analysis of variance (ANOVA) followed by the Tukey and Bonferroni test respectively. A *P* value \<0.05 was selected to be statistically significant. Each point or column represents the mean ± SEM (n = 3); *P* \< 0.05 (\*), *P* \< 0.01 (\*\*), *P* \< 0.001 (\*\*\*).

Results {#s3}
=======

Effect of hydro-alcoholic extract on growth and viability of HUVECs {#s3-1}
-------------------------------------------------------------------

The LDH bioassay was used to measure the viability of HUVECs. The calculated CC~50~ value for DPPE was 679.74 µg/mL, respectively. The mentioned extract was not toxic at 400 µg/mL concentration. On the other hand, 60% viability was observed at a concentration of 600 µg/mL and toxicity effect was increasing at higher doses. Also, the toxicity of 75% and 100% were observed at 800 and 1000 µg/mL concentrations, respectively ([Fig. 2A](#F2){ref-type="fig"}).
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In a dose-dependent behavior, the DPPE showed inhibitory properties on the proliferation of HUVECs and the calculated proliferative inhibitions at doses 50, 100, 200, 400, 600, 800 and 1000 µg/mL were 10%, 15%, 35%, 65%, 83%, 100% and 100%, respectively. From these results, the computed IC~50~ value for DPPE was 328.23 µg/mL ([Fig. 2B](#F2){ref-type="fig"}).

Anti-angiogenic activity of the hydro-alcoholic extract {#s3-2}
-------------------------------------------------------

Three-dimensional culture of HUVECs on cytodex-3D micro-carriers was used as an *in vitro* model to find the possible anti-angiogenic effect of DPPE. After 3 days of treatment, untreated controls showed a branching pattern of tube-like vessels. At the concentration of 100 µg/mL, 30% inhibition of angiogenesis was observed in comparison to controls. At higher doses, the inhibition rate was increased as it was predicted. Therefore, at concentrations of 200 and 400 µg/mL, the observed inhibitory ratios were 45% and 70% ([Fig. 3](#F3){ref-type="fig"}), and the calculated IC~50~ value in this model was 260 µg/mL, respectively.
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Effect of DPPE on VEGF, MMP-2, 9 expressions in HUVECs {#s3-3}
------------------------------------------------------

From real-time PCR results, the *VEGF*, *MMP*-2, and *MMP*-9 mRNA levels decreased upon treatment with extract in comparison with the control (β-actin mRNA expression). Our results unveiled that the mentioned extract significantly decreased the expression of the selected candidate genes in a dose-dependent manner ([Fig. 4A-C](#F4){ref-type="fig"}). The results indicated that the *VEGF* gene expression was decreased by 2.3, 2.6 and 2.73 folds in 200 µg/mL, 400 µg/mL, and 600 µg/mL, respectively. The results for *MMP-2* gene expression showed a decrease of 0.7 and 1.94 folds in 400 µg/mL and 600 µg/mL, respectively. Also, the results for *MMP-9* gene expression showed a decrease of 1.38 and 2.44 folds in 400 µg/mL and 600 µg/mL, respectively.
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Computational results {#s3-4}
---------------------

Molecular docking is an interesting tool among bioinformatics approaches to examine or predict the interaction between ligand-receptor complexes.^[@R16],[@R31]-[@R33]^ At the molecular level, the binding mode of small ligands to large protein targets plays an important role at numerous biological processes.^[@R33],[@R34]^ Though the accurate prediction of interaction between ligand and receptor is a major problem in experimental assays, however, molecular docking simulation (especially fully blind docking approach) can give useful information about the behavior of ligands towards the suspected peripheral, inner/outer and catalytic residues of protein active sites. In this regard, to interpret the results obtained from experimental assays molecular docking can be used as a valuable method to decide about the observed interactions.

Studies reported that DPP grain has comprised from different classes of secondary metabolites including phenolic acids (*i.e.* ferulic acid and chlorogenic acid), flavonoids (*i.e.* apigenin, luteolin, isorhamnetin, apigenin-7-O-β-glucuronide, luteolin-7-O-glucuronide and naringin) and phytosterols (*i.e.* stigmasterol)^[@R28],[@R29]^ ([Fig. 1](#F1){ref-type="fig"}). We used these compounds as input ligands for molecular docking simulation to predict their binding modes into the selected receptors. Our results indicated that these compounds have the potential to interact with the studied receptors and due to their presence in the hydro-alcoholic extract they can exhibit the observed features such as anti-angiogenesis property.

Interaction with ctDNA {#s3-5}
----------------------

Many studies reported that DNA minor groove binding agents are potent inhibitors to target DNA molecules in many different types of human chronic diseases,^[@R35],[@R36]^ which form non-covalent and covalent complexes with DNA.^[@R37]^ These classes of inhibitors have high level of sequence specificity and exhibited a wide range of biological activities from antibacterial to anticancer properties.^[@R37]^ However, studies indicated that phenolic acids and flavonoids can interact with the DNA minor groove.^[@R38],[@R39]^

Circulating tumor DNA (ctDNA) is a small fragment of DNA that found in the bloodstream of cancerous patients.^[@R40]^ Studies suggested that this tumor-based DNA fragment can act as a leader for the migration of tumor cells to other parts of the body.^[@R40]^ Recently, this small fragment of DNA was considered as detectable biomarker in early- and late-Stage human malignancies.^[@R40]^ Also, evidence suggests that ctDNA minor groove binding compounds may be useful to inhibit the tumor migration.^[@R41]^ Herein, to identify the possible binding mode of isolated compounds from DPP into ctDNA molecular docking was performed.

Our results demonstrated that apigenin, luteolin-7-O-β-glucuronide, apigenin-7-O-β-glucuronide and chlorogenic acid were the best interacting compounds ([Fig. 5](#F5){ref-type="fig"}). The calculated docking energies for these compounds were -10.1, -9.38, -8.43 and -8.29 kcal·mol^-1^, respectively.
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Except for naringin, other compounds are located in the ctDNA minor groove. The docking simulation displayed that naringin existed in the major groove region. The calculated docking energy for this compound was -2.93 kcal·mol^-1^, respectively ([Table 1](#T1){ref-type="table"}). On the other hand, stigmasterol was located in ctDNA minor groove but did not make H-bond with this region. The calculated docking energy for this compound was -6.58 kcal·mol^-1^, respectively.

###### The docking energies of ctDNA inhibitors

  ---------------------------- --------------------- ------------- -------------------- --------------------
  **Compound**                 **DE\* (kcal/mol)**   **SE (kT)**   **VDW (kcal/mol)**   **EIE (Kcal/mol)**
  Apigenin                     -10.1                 -7925.22      -10.67               -8.39
  Luteolin-7-O-β-glucuronide   -9.38                 -7976.01      -1.54                -7.09
  Apigenin-7-O-β-glucuronide   -8.43                 -7963.45      -6.54                -6.34
  Cholorogenic acid            -8.29                 -7956.11      -3.71                -5.11
  Isorahamentin                -8.0                  -7962.45      -5.69                -5.23
  Ferulic acid                 -7.69                 -7845.02      -3.55                -6.68
  Stigmasterol                 -6.58                 -6345.70      -0.14                -4.45
  Luteolin                     -5.78                 -7749.12      -1.07                -4.11
  Naringin                     -2.93                 -6348.23      -3.08                -0.02
  ---------------------------- --------------------- ------------- -------------------- --------------------

\* DE: docking energy; SE: solvation energy; VDW: Van der Waals; EIE: Electrostatic Interaction Energy.

From these results, it should be noted that several factors including the variability of ligand structures and ability to construct covalent and/or non-covalent bonds could affect their binding affinity towards the ctDNA minor groove. Studies showed that the distribution of electrostatic charges along with a DNA, that it depends on its sequence, is another factor that can change the binding affinity of a ligand into a DNA clef. Mainly, A:T base pairs having the highest negative charge, at the bottom of DNA minor groove, while the C:G base pairs having the highest positive charges in this region.^[@R42]^ On the other hand, studies suggested that minor groove binding ligands carry a cationic charge, complementing the potential in A:T regions.^[@R42]^ Herein, our results are fully in accordance with previous reports and the studied compounds have interacted with A:T base pairs in the cleft of ctDNA minor groove ([Fig. 6](#F6){ref-type="fig"}).
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Interaction with VEGF/VEGFRs {#s3-6}
----------------------------

At the molecular level, the members of VEGF proteins including VEGF-A (known as VEGF), VEGF-B, VEGF-C, VEGF-D and PIGF (placenta growth factor) play critical roles in vascular biology.^[@R43]^ Among VEGFs, VEGFA is the most widely studied tumor angiogenic factor. Many studies displayed that the *VEGF* gene is a key mediator of angiogenesis in cancer.^[@R44]^ The VEGF protein is homodimeric glycoprotein with a 45 kDa molecular weight.^[@R44]^ This protein is secreted by a numerous of tumors which plays a central role in the expansion of cancerous cells to other healthy tissues.

Many studies indicated that VEGF inhibitors impaired the interaction of this protein with VEGFR-1 and 2.^[@R45],[@R46]^ On the other hand, natural compounds (especially phenolic acids and flavonoids) exhibited anti-angiogenesis activity via inhibition of VEGF signaling pathway.^[@R47]^ According to our results, the evaluated hydro-alcoholic extract significantly decreased the expression of *VEGF* gene. Therefore, to find the possible mode of action associated with DPP compounds the VEGF protein was selected as input receptor for molecular docking simulation.

Molecular docking results indicated that apigenin-7-O-β-glucuronide, apigenin, isorhamnetin and chlorogenic acid were the best interacting compounds with the suspected binding residues at the VEGF active site ([Fig. 7](#F7){ref-type="fig"}). The calculated docking energies for these compounds were -9.6, -7.8, -6.7 and -6.3 kcal·mol, respectively. Ferulic acid was the weakest interacted compound with this receptor. The computed docking energy for this compound was -4.3 kcal·mol^-1^, respectively.
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Also, among docked compounds, chlorogenic acid, isorhamnetin, luteolin-7-O-β-glucuronide and ferulic acid were the best interacting compounds with VEGFR-1 ([Fig. 8](#F8){ref-type="fig"}). The computed docking energies for these compounds were -8.9, -8.3, -7.6 and -7.1 kcal·mol^-1^ respectively. Stigmasterol was the weakest compound with this receptor. The calculated docking energy for this compound was -3.9 kcal·mol^-1^.
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According to our molecular docking results, apigenin, naringin, chlorogenic acid and luteolin were the best interacting compounds with VEGFR-2 ([Fig. 9](#F9){ref-type="fig"}). The calculated docking energies for these compounds were -9.4, -8.9, -7.6 and -7.3 kcal·mol^-1^, respectively. Except for stigmasterol, other compounds were located in the VEGFR-2 active site. The observed docking energy for this compound was -3.5 kcal·mol^-1^ which did not make H-bond with the existed residues in this region.
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The detailed interaction energies for all docked compounds are listed in [Table 2](#T2){ref-type="table"}.

###### The docking energies of VEGF/VEGFR inhibitors

  ---------------------------- -------------- ------------------- ------------- -------------------- --------------------
  **Compound**                 **Receptor**   **DE (kcal/mol)**   **SE (kT)**   **VDW (kcal/mol)**   **EIE (kcal/mol)**
  Stigmasterol                 VEGF           -5.6                -2068.628     -1.2979              -0.07277
                               VEGFR-1        -3.9                -8359.984     -1.1157              -0.31115
                               VEGFR-2        -3.5                -5435.427     -0.0564              -0.29491
  Apigenin                     VEGF           -7.8                -2096.281     -3.64048             -9.65219
                               VEGFR-1        -6.1                -8387.301     -5.10059             -4.2378
                               VEGFR-2        -9.4                -5494.698     -2.74363             -5.12448
  Apigenin-7-O-β-glucuronide   VEGF           -9.6                -2080.67      -7.73188             -13.7057
                               VEGFR-1        -5.7                -8352.803     -9.56820             -10.9582
                               VEGFR-2        -6.8                -5488.201     -10.7391             -7.47193
  Chlorogenic acid             VEGF           -6.3                -2090.167     -7.0811              -5.61221
                               VEGFR-1        -8.9                -8367.643     -3.0391              -7.09720
                               VEGFR-2        -7.6                -5465.598     -6.0912              -9.079410
  Naringin                     VEGF           -4.5                -2057.588     -3.88656             -1.193673
                               VEGFR-1        -5.6                -8321.324     -1.37514             -2.062841
                               VEGFR-2        -8.9                -5451.272     -1.89640             \- 1.170682
  Luteolin                     VEGF           -5.9                -2095.77      -10.7339             -6.130221
                               VEGFR-1        -5.1                -8358.241     -6.7795              -7.786643
                               VEGFR-2        -7.3                -5494.300     -8.7790              \- 5.377954
  Luteolin-7-O-β-glucuronide   VEGF           -5.7                -2070.673     -8.90761             -4.3109123
                               VEGFR-1        -7.6                -83456.129    -6.27990             -8.7433921
                               VEGFR-2        -5.2                -5487.870     -8.84682             -2.0008144
  Isorahamentin                VEGF           -6.7                -2095.413     -1.29281             -3.7180134
                               VEGR-1         -8.3                -8367.210     -5.96710             -5.2834756
                               VEGFR-2        -5.8                -5495.932     -4.83243             -2.210868
  Ferulic acid                 VEGF           -4.3                -2101.615     -4.85457             -3.572598
                               VEGFR-1        -7.1                -8329.320     -5.03915             -4.097232
                               VEGFR-2        -7.2                -5499.175     -3.77985             -3.775500
  ---------------------------- -------------- ------------------- ------------- -------------------- --------------------

DE: docking energy; SE: solvation energy; VDW: Van der Waals; EIE: Electrostatic Interaction Energy.

We observed that chlorogenic acid showed binding affinity to interact with ctDNA, VEGF and VEGF receptors. Apigenin interacted with ctDNA, VEGF and VEGFR-2. Also, apigenin-7-O-β-glucuronide has affinity to interact with ctDNA and VEGF. On the other hand, luteolin-7-O-β-glucuronide interacted with ctDNA and VEGFR-1. Except stigmasterol, other polyphenols interacted with critical residues in the structure of VEGF and VEGFRs with different binding energies. However, due to the critical roles of VEGF and VEGFRs in metastasis and angiogenesis,^[@R31],[@R48]^ among receptor tyrosine kinases (RTKs) their mode of action have widely studied over the past decades.^[@R49]^ These proteins are responsible for inducing angiogenesis and activating of PLCγ-PKC-MAPK signaling pathway.^[@R48]^ The VEGF signaling pathway is triggered with the interaction between VEGF and its specific receptor tyrosine kinases and activating the receptors through auto-phosphorylation of intrinsic tyrosine kinase domain.^[@R50]^ As shown in [Fig. 10](#F10){ref-type="fig"}, the expression of VEGF-A can regulate the expression of other upstream or downstream proteins. Therefore, the inhibition of the interaction between VEGF and VEGFRs is an important way to prevent angiogenesis and the development of malignancy to other tissues. Various types of VEGF signaling cascade inhibitors including antagonistic VEGF mutants, soluble receptors, receptor antagonists, monoclonal antibodies, and deterrents of VEGF receptor function are used as anti-cancer drugs.^[@R51]^
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The *MMP-2* and *MMP-9* genes also participate in the angiogenesis process. Studies indicated that *MMP-2/9* genes play a central role in the high invasion ability of angiogenic cells.^[@R52]^ The signaling pathways for these genes suggested that they are directly involved in the expression of VEGF-A to induce the inflammation and angiogenesis.^[@R53]^ Different factors including cytokines, growth factors and mechanical stress can regulate or activate MMPs.^[@R54],[@R55]^ VEGF is a potent enhancer to release the *MMP-2* and *MMP-9* by endothelial cells and induces the vascular permeability to allow the permeation of plasma proteins (*e.g*. fibronectin).^[@R55],[@R56]^ In the activated endothelial cells integrin receptors such as α5β1 and αvβ3 are suitable targets to interact with fibronectin and fibrin.^[@R57],[@R58]^ Studies showed that MMP-2 can bind to αvβ3 integrin^[@R59]^ to trigger the invading potential of endothelial cells.^[@R55]^ Therefore, the inhibition of VEGF and MMPs expression can delay the angiogenesis and cell malignancy.

It should be noted that the edible medicinal plants\' hydro-alcoholic extracts exhibited anti-angiogenesis property via the inhibition of cell proliferation and suppression the VEGF secretion. Hydro-alcoholic extracts comprised many different anti-angiogenic constitutes, which showed their inhibitory potential mainly via down-regulation of essential mediators such as VEGF and MMPs.^[@R60],[@R61]^ The anti-angiogenic activity of medicinal plants hydro-alcoholic extracts significantly depends on the administrated doses in the *in vitro* and *in vivo* models.^[@R62],[@R63]^ Studies reported that the inhibitory properties of hydro-alcoholic extracts are directly associated with the presence of plant secondary metabolites from polyphenols to phytosterols.^[@R64]-[@R66]^, Therefore, each plant hydro-alcoholic extract has mild to strong anti-angiogenic activity due to the variability of its secondary metabolites.

Discussion {#s4}
==========

Date palm is one of the most important planted trees for humans since ancient times for both medicinal uses and religious ceremonies.^[@R67]^ Its sweet fruits and pollens (the male reproductive cells of palm flowers) widely consumed throughout the world,^[@R68]^ and it is estimated that about 1000 tons of date pollens are produced every year in the Arabic regions.^[@R19]^

As mentioned in above sections, studies reported that DPP comprised different classes of natural products including non-flavonoids (especially phenolic acids), flavonoids,^[@R29]^ amino acids including aspartic, proline, threonine, phenylalanine, alanine, glycine, arginine, methionine, isoleucine, leucine, tyrosine, glutamine, lysine, histidine, valine, and serine,^[@R69]^ vitamins (B1, B2, B12, A, D, C, E),^[@R68]^ fatty acids, phytosterols,^[@R68]^ and mineral and trace elements (e.g. potassium, calcium, sodium, manganese, phosphorous, zinc, iron, selenium).^[@R68]-[@R70]^

Studies reported that the consumption of DPP can fortify the size and weight of female sex organs.^[@R19]^ Also, it can change or enhance the secretion of sexual hormones such as testosterone,^[@R71]^ estrogen and progesterone.^[@R72]^ The role of DPP grains in the improvement of testicular dysfunction induced by cadmium chloride^[@R73]^ and thyroid disorders in male rats^[@R74]^ is well documented.

The administration of DPP to male animals (rats and rabbits) displayed spermatogenic property and increased the count of sperms, sperms quality, sperms motility and the size of the testis.^[@R75],[@R76]^ The DPPs also showed antioxidant activity^[@R67]^ and decreased the activity of catalase, glutathione peroxidase^[@R77]^ and superoxide dismutase.^[@R67],[@R73]^ Though the protective roles of DPP grains against male infertility were previously reported,^[@R68],[@R78]^ however, its anti-angiogenic activity was not reported and as the first study, our investigation showed that in addition to sexual effects this natural product has a significant anti-cancer property. We showed that this date palm derived product has significant anti-angiogenesis activity. Of course, it should be noted that the behavior of plant extracts in real phase (i.e. Clinical studies) may show different pattern due to the complexity of human body and the involved signaling pathways. Therefore, to gain the best results from clinical investigations various factors including the optimum doses of plant extract, the age of patients and the time of administration should be considered in order to approve the efficacy of the examined plant extract.

Flavonoids are abundant groups of bioactive secondary metabolites widely distributed in fruits and vegetables.^[@R15],[@R16],[@R79]^ Phenolic acids and flavonoids exhibited a wide range of biological activities from anti-diabetic to anti-cancer properties.^[@R80]^ Thanks to their anti-cancer activities, thousands of papers have published over the past decade to highlight this fact that how these compounds are effective agents in the prevention of cancer and the associated disorders. These natural compounds have low or no adverse effects for the human body and the regular consumption of foods rich in flavonoids and phenolic acids can improve the quality of life. Recently, Al-Samarrai et al isolated different classes of natural products from Iraqi DPP grains. Polyphenols including isorhamnetin (122.251 µg/g), chlorogenic acid (71.146 µg/g), ferulic acid (99.188 µg/g), naringin (64.574 µg/g), apigenin (109.117 µg/g), apigenin-7-O-β glycopyranoside (48.391 µg/g), luteolin (28.883 µg/g) and luteolin-7-O-β-glucuronide (18.291 µg/g) were the most abundant compounds isolated from DPPs.^[@R29]^ Generally, food products containing high levels of natural products including flavonoids and phenolic acids, vitamins, minerals and trace elements have considered as "*functional foods*" to provide many health benefits for humans.^[@R81],[@R82]^

Many studies reported that the presence of essential bioactive compounds in plant-based foods can improve the physiological and biochemical condition of human health,^[@R83]^ and therefore the regular consumption of these products improve the quality of life.^[@R84]^ The consumption of foods originated from edible plants decreased the incidences of certain chronic diseases and improved lifestyle habits and life expectancies.^[@R85]^ On the other hand, the anticancer activities of functional foods^[@R86],[@R7]^ have been investigated in years and the correlation between healthy diet and cancer prevention is well documented.^[@R88]^

As previously reported, the DPP grains included different classes of bioactive compounds which can be considered as new functional food to use as a dietary supplement in the treatment of different diseases. The use of "functional food" term for DPP is relatively depending on the applicability of this product in the human diet. For years, this part of date palm has wasted in local regions due to the lacking of food conversion industries to prepare it for commercial uses. Beyond the biological and pharmacological activities of DPP grains, the trading of this product can improve the economic condition of producers to sell DPP as a valuable food product like other agricultural products. However, we selected the presented polyphenols in DPP to examine their possible interaction with proteins involved in angiogenesis.

Our results unveiled that the titled compounds showed different affinity to interact with the studied receptors. The observed variable binding energies for docked ligands may be due to the structural variation of these compounds. Many studies suggested that the chemical structure of polyphenols has a pivotal role in the interaction of these compounds with molecular targets. The number of attached --OH groups, sugar units, methylation, the position of B-ring, C2-C3 double bond and the molecular weight of polyphenols are other important features affected the binding affinity of these compounds.^[@R15],[@R16]^ However, studied showed that flavonoids have strong anti-angiogenic properties^[@R89],[@R90]^ and researchers suggested that these compounds are useful targets to consider their structure backbones to design new effective supplementary agents in the pre-treatment of cancer. On the other hand, each angiogenesis study aims to achieve an acceptable agent for further experimental and clinical studies. As a general consensus, our results for evaluating the anti-angiogenic activity of DPP hydro-alcoholic extract is fully in line with previous studies to identify the inhibitory properties of medicinal plant hydro-alcoholic extracts.

Conclusion {#s5}
==========

DPP is orally consumed as functional food which possesses numerous health benefits as anti-diabetic, antioxidant, anti-inflammation and protective effect against male infertility. As the first study, we evaluated its potential to inhibit angiogenesis and the results successfully confirmed our hypothesis. Further *in vivo* and clinical studies regarding DPP grains to use as a useful supplementary agent in the pre-treatment of cancer are highly recommended.
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Research Highlights {#s11}
===================

What is the current knowledge? {#research1}
------------------------------

1.  √ Date palm pollen (DPP) is a valuable source of natural products (polyphenols to phytosterols) to treat human diseases.

What is new here? {#research2}
-----------------

1.  √ As the first report, the study discuss the probable mechanism for anti-angiogenesis activity of DPP

2.  √ This study provides useful information about this food product to use as supplementary agent in cancer therapy strategies.
